Lupin sees significant upside from $150-million Symbiomix acquisition

The drugmaker expects a fillip from the USD 1 billion market that Solosec, Symbiomixâs lead product, addresses.

Paid Prime Membership on Primevideo.com

Comments

RIVER Collection launch: Latest styles from your favourite designers | Made for Amazon | Up to 20% off - Launching on 1st